These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 28901480)

  • 1. Radioiodine-labeled anti-epidermal growth factor receptor binding bovine serum albumin-polycaprolactone for targeting imaging of glioblastoma.
    Li C; Tan J; Chang J; Li W; Liu Z; Li N; Ji Y
    Oncol Rep; 2017 Nov; 38(5):2919-2926. PubMed ID: 28901480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression.
    Li W; Liu Z; Li C; Li N; Fang L; Chang J; Tan J
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):619-32. PubMed ID: 26573511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of therapeutic effectiveness of (131)I-antiEGFR-BSA-PCL in a mouse model of colorectal cancer.
    Li W; Ji YH; Li CX; Liu ZY; Li N; Fang L; Chang J; Tan J
    World J Gastroenterol; 2016 Apr; 22(14):3758-68. PubMed ID: 27076760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor Effect of Nanoparticle
    Ming H; Fang L; Gao J; Li C; Ji Y; Shen Y; Hu Y; Li N; Chang J; Li W; Tan J
    AJR Am J Roentgenol; 2017 May; 208(5):1116-1126. PubMed ID: 28301223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
    Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
    Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.
    Liu X; Dong C; Shi J; Ma T; Jin Z; Jia B; Liu Z; Shen L; Wang F
    Oncotarget; 2017 Jan; 8(4):6364-6375. PubMed ID: 28031526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.
    Kaluzova M; Bouras A; Machaidze R; Hadjipanayis CG
    Oncotarget; 2015 Apr; 6(11):8788-806. PubMed ID: 25871395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
    Israel I; Brandau W; Farmakis G; Samnick S
    Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591.
    Tolmachev V; Varasteh Z; Honarvar H; Hosseinimehr SJ; Eriksson O; Jonasson P; Frejd FY; Abrahmsen L; Orlova A
    J Nucl Med; 2014 Feb; 55(2):294-300. PubMed ID: 24408895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
    Bouras A; Kaluzova M; Hadjipanayis CG
    J Neurooncol; 2015 Aug; 124(1):13-22. PubMed ID: 25981803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced tumor retention of radioiodinated anti-epidermal growth factor receptor antibody using novel bifunctional iodination linker for radioimmunotherapy.
    Kim EJ; Kim BS; Choi DB; Chi SG; Choi TH
    Oncol Rep; 2016 Jun; 35(6):3159-68. PubMed ID: 27035553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model.
    Kao HW; Lin YY; Chen CC; Chi KH; Tien DC; Hsia CC; Lin MH; Wang HE
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3180-5. PubMed ID: 23628334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy.
    Jung KH; Choe YS; Paik JY; Lee KH
    J Nucl Med; 2011 Sep; 52(9):1457-64. PubMed ID: 21849406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
    Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
    Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo.
    Zhong Y; Wang C; Cheng R; Cheng L; Meng F; Liu Z; Zhong Z
    J Control Release; 2014 Dec; 195():63-71. PubMed ID: 25108151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts.
    Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X
    Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
    Wu J; Zhao J; Zhang B; Qian Y; Gao H; Yu Y; Wei Y; Yang Z; Jiang X; Pang Z
    Int J Nanomedicine; 2014; 9():5261-71. PubMed ID: 25419130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.
    Sarkaria JN; Carlson BL; Schroeder MA; Grogan P; Brown PD; Giannini C; Ballman KV; Kitange GJ; Guha A; Pandita A; James CD
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2264-71. PubMed ID: 16609043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2.
    Martens T; Laabs Y; Günther HS; Kemming D; Zhu Z; Witte L; Hagel C; Westphal M; Lamszus K
    Clin Cancer Res; 2008 Sep; 14(17):5447-58. PubMed ID: 18765536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.